(AM) Dassault Aviation - Overview
Stock: Military Aircraft, Business Jets, Drones, Maintenance Services
Dividends
| Dividend Yield | 1.54% |
| Yield on Cost 5y | 5.65% |
| Yield CAGR 5y | -21.29% |
| Payout Consistency | 88.5% |
| Payout Ratio | 47.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.0% |
| Relative Tail Risk | -11.4% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.20 |
| Alpha | 44.19 |
| Character TTM | |
|---|---|
| Beta | -0.055 |
| Beta Downside | 0.030 |
| Drawdowns 3y | |
|---|---|
| Max DD | 22.02% |
| CAGR/Max DD | 1.24 |
Description: AM Dassault Aviation December 19, 2025
Dassault Aviation SA (ticker AM) is a French-based, publicly traded aerospace & defense company that designs and manufactures military aircraft, business jets, and space systems.
Its flagship products include the Rafale omni-role fighter, the nEUROn unmanned combat drone, and the Falcon family of business jets, complemented by multi-mission platforms for maritime surveillance, training, scientific research, intelligence, and medical evacuation.
The firm operates roughly 2,100 Falcon jets and 1,000 military aircraft worldwide, and it monetises its expertise through maintenance, repair, overhaul (MRO) services, aircraft leasing, and the development of flight-simulation tools.
Founded in 1916 and headquartered in Paris, Dassault Aviation is a subsidiary of Groupe Industriel Marcel Dassault S.A.
Key recent metrics: FY 2023 revenue was €13.5 billion with an order backlog exceeding €15 billion, while R&D intensity remains high at about 12 % of sales-a level that supports its advanced fighter and autonomous-drone programs. The company’s performance is sensitive to two primary drivers: (1) sovereign defense spending cycles, especially in Europe and the Middle East, and (2) the demand for premium business jets, which correlates with global high-net-worth individual wealth and corporate travel trends.
For a deeper quantitative view of Dassault Aviation’s valuation metrics, you might explore the analyst toolkit on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 1.59b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 0.82 > 1.0 |
| NWC/Revenue: 10.98% < 20% (prev 25.92%; Δ -14.94% < -1%) |
| CFO/TA 0.12 > 3% & CFO 3.92b > Net Income 1.59b |
| Net Debt (-2.13b) to EBITDA (1.23b): -1.73 < 3 |
| Current Ratio: 1.05 > 1.5 & < 3 |
| Outstanding Shares: last quarter (78.2m) vs 12m ago -4.92% < -2% |
| Gross Margin: 40.43% > 18% (prev 0.05%; Δ 4038 % > 0.5%) |
| Asset Turnover: 42.80% > 50% (prev 27.34%; Δ 15.46% > 0%) |
| Interest Coverage Ratio: 20.55 > 6 (EBITDA TTM 1.23b / Interest Expense TTM 43.7m) |
Beneish M -3.73
| DSRI: 0.57 (Receivables 1.75b/1.60b, Revenue 11.68b/6.14b) |
| GMI: 0.12 (GM 40.43% / 4.76%) |
| AQI: 0.79 (AQ_t 0.11 / AQ_t-1 0.14) |
| SGI: 1.90 (Revenue 11.68b / 6.14b) |
| TATA: -0.07 (NI 1.59b - CFO 3.92b) / TA 32.13b) |
| Beneish M-Score: -3.73 (Cap -4..+1) = AAA |
What is the price of AM shares?
Over the past week, the price has changed by -0.88%, over one month by +8.71%, over three months by +17.23% and over the past year by +52.99%.
Is AM a buy, sell or hold?
What are the forecasts/targets for the AM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 331.3 | 4.5% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 386.7 | 22% |
AM Fundamental Data Overview February 04, 2026
P/E Trailing = 31.7317
P/E Forward = 19.084
P/S = 3.6599
P/B = 4.0114
P/EG = 1.4597
Revenue TTM = 11.68b EUR
EBIT TTM = 898.4m EUR
EBITDA TTM = 1.23b EUR
Long Term Debt = 16.7m EUR (from longTermDebt, last quarter)
Short Term Debt = 31.1m EUR (from shortTermDebt, last quarter)
Debt = 203.7m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = -2.13b EUR (from netDebt column, last quarter)
Enterprise Value = 23.14b EUR (24.62b + Debt 203.7m - CCE 1.69b)
Interest Coverage Ratio = 20.55 (Ebit TTM 898.4m / Interest Expense TTM 43.7m)
EV/FCF = 7.00x (Enterprise Value 23.14b / FCF TTM 3.30b)
FCF Yield = 14.28% (FCF TTM 3.30b / Enterprise Value 23.14b)
FCF Margin = 28.29% (FCF TTM 3.30b / Revenue TTM 11.68b)
Net Margin = 13.61% (Net Income TTM 1.59b / Revenue TTM 11.68b)
Gross Margin = 40.43% ((Revenue TTM 11.68b - Cost of Revenue TTM 6.96b) / Revenue TTM)
Gross Margin QoQ = 41.96% (prev 60.60%)
Tobins Q-Ratio = 0.72 (Enterprise Value 23.14b / Total Assets 32.13b)
Interest Expense / Debt = 1.95% (Interest Expense 3.98m / Debt 203.7m)
Taxrate = 25.55% (114.8m / 449.2m)
NOPAT = 668.8m (EBIT 898.4m * (1 - 25.55%))
Current Ratio = 1.05 (Total Current Assets 27.05b / Total Current Liabilities 25.77b)
Debt / Equity = 0.03 (Debt 203.7m / totalStockholderEquity, last quarter 6.19b)
Debt / EBITDA = -1.73 (Net Debt -2.13b / EBITDA 1.23b)
Debt / FCF = -0.64 (Net Debt -2.13b / FCF TTM 3.30b)
Total Stockholder Equity = 6.04b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.83% (Net Income 1.59b / Total Assets 32.13b)
RoE = 26.31% (Net Income TTM 1.59b / Total Stockholder Equity 6.04b)
RoCE = 14.82% (EBIT 898.4m / Capital Employed (Equity 6.04b + L.T.Debt 16.7m))
RoIC = 10.97% (NOPAT 668.8m / Invested Capital 6.10b)
WACC = 5.68% (E(24.62b)/V(24.83b) * Re(5.71%) + D(203.7m)/V(24.83b) * Rd(1.95%) * (1-Tc(0.26)))
Discount Rate = 5.71% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.83%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈2.83b ; Y1≈1.86b ; Y5≈848.5m
Fair Price DCF = 376.1 (EV 27.04b - Net Debt -2.13b = Equity 29.16b / Shares 77.5m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: -13.15 | EPS CAGR: -39.26% | SUE: 0.0 | # QB: 0
Revenue Correlation: -23.72 | Revenue CAGR: 1.35% | SUE: 0.16 | # QB: 0
EPS next Year (2026-12-31): EPS=16.69 | Chg30d=-0.468 | Revisions Net=-7 | Growth EPS=+29.7% | Growth Revenue=+21.4%